Adjuvant Systemic Therapy | Lunch and Learn - Dec 2014 | Dr. Caroline Lohrisch
Breast Cancer
Calvin Thigpen, M.D. July 18, 2014. Study 5 things in oncology, they should be: 1. Breast Cancer 2. Lung Cancer 3. Colon Cancer 4. Prostate Cancer 5.
NCCN and NCCN Clinical Practice Guidelines in Oncology™ Joan S. McClure, MS Senior Vice President of Clinical Information and Publications National Comprehensive.
Carlos L. Arteaga, M.D. Departments of Medicine and Cancer Biology Breast Cancer Research Program Vanderbilt Ingram Comprehensive Cancer Center Vanderbilt.
PierFranco Conte Dipartimento di Oncologia e Ematologia Università di Modena e Reggio Emilia Highlights in the management of breast cancer: Lapatinib Rome,
Highlights in the Management of Breast Cancer Rome, May 25-26, 2007 CLINICAL CASE Dott.ssa Marinella Zilli Cattedra di Oncologia Medica Università “G.
Update on the 2006 San Antonio Breast Cancer Symposium Helen K. Chew, MD, FACP UC Davis Cancer Center.
Controversias y estrategias terapéuticas prometedoras en el cáncer de mama HER2 positivo Francisco J. Esteva, MD, PhD Professor of Medicine Department.
Clinical Application of HER2-Directed Therapies in Breast Cancer
The Use of Trastuzumab in the Elderly in the Adjuvant Setting and After Disease Progression in Patients with HER2-Positive Advanced Breast Cancer Dall.
ER signalling in HER2-positive breast cancer 18 th Annual Perspectives in Breast Cancer New York, August 18 th 2011 Ruth M. O’Regan, MD Professor and Vice-Chair.
